Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Onfekafusp alfa |
| Trade Name | |
| Synonyms | Fibromun|L19-TNF-alpha|L19TNF |
| Drug Descriptions |
Onfekafusp alfa comprises TNFalpha linked to a single chain variable fragment targeting fibronectin extra-domain B, which may increase antitumor immune response (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | 1957239-88-1 |
| NCIT ID | C166939 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dacarbazine + Onfekafusp alfa | Dacarbazine Onfekafusp alfa | 0 | 1 |
| Daromun + Onfekafusp alfa | Daromun Onfekafusp alfa | 0 | 1 |
| Doxorubicin + Onfekafusp alfa | Doxorubicin Onfekafusp alfa | 0 | 2 |
| Lomustine + Onfekafusp alfa | Lomustine Onfekafusp alfa | 0 | 2 |
| Onfekafusp alfa | Onfekafusp alfa | 0 | 0 |
| Onfekafusp alfa + Pembrolizumab | Onfekafusp alfa Pembrolizumab | 0 | 1 |
| Onfekafusp alfa + Temozolomide | Onfekafusp alfa Temozolomide | 0 | 1 |